Chrysophanol-8-O-glucoside, an anthraquinone derivative in rhubarb, has antiplatelet and anticoagulant activities

Journal of Pharmacological Sciences

Volumn 118, Issue 2, 2012, Pages 245-254

  Seo, Eun Ji ^a   Ngoc, Tran Minh ^b   Lee, Sun Mee ^c   Kim, Yeong Shik ^d   Jung, Yi Sook ^a,e  

^a Ajou University School of Medicine   (South Korea)

^b National Institute of Drug Quality Control   (Viet Nam)

^c Sungkyunkwan University   (South Korea)

^d Seoul National University   (South Korea)

^e Ajou University   (South Korea)

Author keywords

Anthraquinone derivative; Anticoagulant; Antiplatelet; Chrysophanol 8 O glucoside; Rhubarb

Indexed keywords

ANTHRAQUINONE DERIVATIVE; CHRYSOPHANIC ACID DERIVATIVE; CHRYSOPHANOL 8 O GLUCOSIDE; COLLAGEN; INTRINSIC FACTOR; PHOSPHATIDYLSERINE; RHUBARB EXTRACT; THROMBIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLEEDING TIME; BLOOD CLOTTING; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; EX VIVO STUDY; IC 50; MEDICINAL PLANT; MOUSE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; RAT; RHUBARB; THROMBOCYTE AGGREGATION; TRADITIONAL MEDICINE;

EID: 84863124454     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.11123FP     Document Type: Article

References (43)

1. Davi G, Patrono C. Platelet activation and atherothrombosis. New Engl J Med. 2007;357:2482-2494.
2. Gross PL, Weitz JI. New antithrombotic drugs. Clin Pharmacol Ther. 2009;86:139-146.
3. Kinoshita Y, Matsumoto N, Watanabe M, Takeba Y, Yoshida Y, Ohba K, et al. Comparison of the effects of omeprazole and rabeprazole on ticlopidine metabolism in vitro. J Pharmacol Sci. 2011;117:19-26.
4. Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007;70:461-477. (Pubitemid 46595760)
5. Siegers CP, von Hertzberg-Lottin E, Otte M, Schneider B. Anthranoid laxative abuse-a risk for colorectal cancer? Gut. 1993; 34:1099-1101. (Pubitemid 23245363)
6. Cyong J, Matsumoto T, Arakawa K, Kiyohara H, Yamada H, Otsuka Y. Anti-acteroides fragilis substance from rhubarb. J Ethnopharmacol. 1987;19:279-283.
7. Darias V. Analgesic activity of some phenolic components in rhubarb. Farmaco (Ed Sci). 1987;33:460-465.
8. Matsuda H, Kageura T, Morikawa T, Toguchida I, Harima S, Yoshikawa M. Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-acivated macrophages. Bioorg Med Chem Lett. 2000;21:323-327. (Pubitemid 30125181)
9. Aburjai TA. Anti-platelet stilbenes from aerial parts of Rheum palaestinum. Phytochemistry. 2000;55:407-410.
10. Park EK, Choo MK, Yoon HK, Kim DH. Antithrombotic and antiallergic activities of rhaponticin from Rhei Rhizoma are activated by human intestinal bacteria. Arch Pharm Res. 2002;25: 528-533.
11. Okabe H, Matus K, Nishioka I. Studies on Rhubarb (Rhei Rhizoma) II, anthraquinone glycosides. Chem Pharm Bull. 1973;21:1254-1260.
12. Ko SK, Whang WK, Kim IK. Anthraquinone and stilbene derivatives from the cultivated Korean Rhubarb Rhizomes. Arch Pharm Res. 1995;18:282-288.
13. Ngoc TM, Minh PTH, Hung TM, Thuong PT, Lee I, Min BS, et al. Lipoxygenase inhibitory constituents from rhubarb. Arch Pharm Res. 2008;31:598-605.
14. Seo EJ, Lee DU, Kwak JH, Lee SM, Kim YS, Jung YS. Anti-platelet effects of Cyperus rotundus and its component (+)-nootkatone. J Ethrnopharmacol. 2011;135:48-54.
15. Jung YS, Kim MH, Lee SH, Baik EJ, Park SW, Moon CH. Antithrombotic effect of onion in streptozotocin-induced diabetic rat. Prostaglandins Leukot Essent Fatty Acids. 2002;66:453-458. (Pubitemid 34785778)
16. Mustard KF, Perry DW, Ardlie NG, Packham MA. Preparation of suspensions of washed platelets from humans. Brit J Haematol. 1972;22:193-204.
17. Yuk DY, Ryu CK, Hong JT, Chung KH, Kang WS, Kim Y, et al. Antithrombotic and antiplatelet activities of 2-chloro-3-[4- (ethylcarboxy)-phenyl]-amino-1,4- naphtaoquinone (NQ12), a newly synthesized 1,4-naphthoquinone derivative. Biochem Pharmacol. 2000;60:1001-1008.
18. Cho J, Furie BC, Coughlin SR, Furie B. A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest. 2008;118:1123-1131. (Pubitemid 351364619)
19. Kim JE, Han M, Hanl KS, Kim HK. Vitamin E inhibition on platelet procoagulant activity: involvement of aminophospholipid translocase activity. Thromb Res. 2011;127:435-442.
20. Tsai IL, Lin WY, Teng CM, Ishikawa T, Doong SL, Huang MW, et al. Coumarins and antiplatelet constituents from the root bark of Zanthoxylum schinifolium. Planta Med. 2000;66:618-623.
21. Ballabeni V, Tognolini M, Bertoni S, Bruni R, Guerrini A, Rueda GM, et al. Antiplatelet and antithrombotic activities of essential oil from wild Ocotea quixos (Lam.) Kosterm. (Lauraceae) calices from Amazonian Ecuador. Pharmacol Res. 2007;55:23-30. (Pubitemid 46108583)
22. Chung MI, Gan KH, Lin CN, Ko FN, Teng CM. Antiplatelet effects and vasorelaxing action of some constituents of Formosan plants. J Nat Prod. 1993;56:929-934.
23. Meng G, Liu Y, Lou C, Yang H. Emodin suppresses lipopolysaccharide- induced pro-inflammatory responses and NF-kB activation by disrupting lipid rafts in CD14-negative endothelial cells. Br J Pharmacol. 2010;161:1628-1644.
24. Zhao YL, Wang JB, Zhou GD, Shan LM, Xiao XH. Investigations of free anthraquinones from rhubarb against alpha-naphthylisothiocyanate- induced cholestatic liver injury in rats. Basic Clin Pharmacol Toxicol. 2009;104:463-469.
25. Lu CC, Yang JS, Huang AC, Hsia TC, Chou ST, Kuo CL, et al. Chrysophanol induces necrosis through the production of ROS and alteration of ATP levels in J5 human liver cancer cells. Mol Nutr Food Res. 2010;54:967-976.
26. Lee MS, Sohn CB. Anti-diabetic properties of chrysophanol and its glucoside from rhubarb rhizome. Biol Pharm Bull. 2008; 31:2154-2157.
27. He ZH, He MF, Ma SC, But PP. Anti-angiogenic effects of rhubarb and its anthraquinone derivatives. J Ethnopharmacol. 2009; 121:313-317.
28. Regev-Shoshani G, Shoseyov O, Bilkis I, Kerem Z. Glycosylation of resveratrol protects it from enzymic oxidation. Biochem J. 2003;374:157-163. (Pubitemid 37046939)
29. Kikuchi M, Mano N, Uehara Y, Machida K, Kikuchi M. Cytotoxic and EGFR tyrosine kinase inhibitory activities of aglycone derivatives obtained by enzymatic hydrolysis of oleoside-type secoiridoid glucosides, oleuropein and ligustroside. J Nat Med. 2011;65:237-240.
30. Kwon SH, Kang MJ, Huh JS, Ha KW, Lee JR, Lee SK, et al. Comparison of oral bioavailability of genistein and genistin in rats. Int J Pharmaceut. 2007;337:148-154. (Pubitemid 46756046)
31. Allred CD, Ju YH, Allred KF, Chang J, Helferich WG. Dietary genistin stimulates growth of estrogen-dependent breast cancer tumors similar to that observed with genistein. Carcinogenesis. 2001;22:1667-1673. (Pubitemid 32952145)
32. Jennings LK. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost. 2009;102:248-257.
33. Hardy AR, Jones ML, Mundell SJ, Poole AW. Reciprocal crosstalk between P2Y1 and P2Y12 receptors at the level of calcium signaling in human platelets. Blood. 2004;104:1745-1752. (Pubitemid 39202283)
34. Egashira T, Takayama F, Yamanaka Y. The inhibition of monoamine oxidase activity by various antidepressants: differences found in various mammalian species. Jpn J Pharmacol. 1999; 81:115-121. (Pubitemid 29479063)
35. Hirose H, Kimura T, Okada M, Itoh Y, Ishida F, Mochizuki N, et al. Antiplatelet and antithrombotic effects of a novel selective phosphodiesterase 3 inhibitor, NSP-513, in mice and rats. Jpn J Pharmacol. 2000;82:188-198. (Pubitemid 30209526)
36. Martignoni M, Groothuis GM, de Kanter R. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol. 2009;2:875-894. (Pubitemid 44911538)
37. Dingell JV, Sulser F, Gillette JR. Species differences in the metabolism of imipramine and desmethylimipramine (DMS). J Pharmacol Exp Ther. 1964;143:14-22.
38. Boron WF, Boulpaep EL. Medical physiology: a cellular and molecular approach. Philadelphia, Pennsylvania: Elsevier Inc; 2005. p. 529-550.
39. Lentz BR. Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog Lipid Res. 2003;42:423-438. (Pubitemid 36694106)
40. Cho HJ, Choi SA, Kim CG, Jung TS, Hong JH, Rhee MH, et al. Spinach saponin-enriched fraction inhibits platelet aggregation in cAMP- and cGMP-dependent manner by decreasing TXA2 production and blood coagulation. Biomol Ther. 2011;19: 218-223.
41. Mehta SR, Yusuf S. Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention. J Am Coll Cardiol. 2003;41:79S-88S. (Pubitemid 36223351)
42. Heemskerk JW, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost. 2002;88:186-193. (Pubitemid 34873696)
43. Pan CJ, Wang J, Huang N. Preparation, characterization and in vitro anticoagulation of emodin-eluting controlled biodegradable stent coatings. Colloids Surf B Biointerfaces. 2010;77:155-160.